- Home
- NRXP vs TACT Comparison
NRXP vs TACT Comparison
Compare NRXP & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- TACT
- Stock Information
- Founded
- NRXP 2015
- TACT 1996
- Country
- NRXP United States
- TACT United States
- Employees
- NRXP N/A
- TACT N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- NRXP Health Care
- TACT Technology
- Exchange
- NRXP Nasdaq
- TACT Nasdaq
- Market Cap
- NRXP 58.5M
- TACT 51.0M
- IPO Year
- NRXP N/A
- TACT 1996
- Fundamental
- Price
- NRXP $2.92
- TACT $4.75
- Analyst Decision
- NRXP Strong Buy
- TACT Strong Buy
- Analyst Count
- NRXP 5
- TACT 1
- Target Price
- NRXP $31.40
- TACT $5.00
- AVG Volume (30 Days)
- NRXP 435.6K
- TACT 41.5K
- Earning Date
- NRXP 11-13-2025
- TACT 11-10-2025
- Dividend Yield
- NRXP N/A
- TACT N/A
- EPS Growth
- NRXP N/A
- TACT N/A
- EPS
- NRXP N/A
- TACT N/A
- Revenue
- NRXP N/A
- TACT $47,949,000.00
- Revenue This Year
- NRXP N/A
- TACT $21.67
- Revenue Next Year
- NRXP $395.09
- TACT $7.63
- P/E Ratio
- NRXP N/A
- TACT N/A
- Revenue Growth
- NRXP N/A
- TACT N/A
- 52 Week Low
- NRXP $1.12
- TACT $3.12
- 52 Week High
- NRXP $6.01
- TACT $5.70
- Technical
- Relative Strength Index (RSI)
- NRXP 41.65
- TACT 45.20
- Support Level
- NRXP $3.05
- TACT $4.56
- Resistance Level
- NRXP $3.32
- TACT $4.78
- Average True Range (ATR)
- NRXP 0.22
- TACT 0.25
- MACD
- NRXP -0.05
- TACT -0.05
- Stochastic Oscillator
- NRXP 0.74
- TACT 19.99
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.